Who owns Global X Fds genomic biotech?

Tip: Access positions for across all investors

Analyze quarterly positions in Global X Fds genomic biotech with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Global X Fds genomic biotech stock

Who bought or sold Global X Fds genomic biotech this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Advisor Group Holdings 330.00 $3.0k -41% Sep 2025
 View chart

Who sold out of Global X Fds genomic biotech?

Fund or Company Name Date Sold Shares Held Valued At
Flow Traders US Jun 2025 239k $2.0M
Two Sigma Investments Jun 2025 113k $956k
IHT Wealth Management Jun 2025 67k $563k
Insight Advisors, LLC/ PA Jun 2025 60k $503k
Armis Advisers Jun 2025 51k $432k
Jane Street Jun 2025 32k $270k
Private Advisor Jun 2025 24k $198k
Raymond James Financial Jun 2025 22k $185k
Smartleaf Asset Management Jun 2025 20k $164k
Atria Investments Jun 2025 19k $156k
Centaurus Financial Jun 2025 15k $126k
HighTower Advisors Jun 2025 14k $121k
Stifel Financial Jun 2025 13k $110k
Sanctuary Advisors Sep 2025 12k $98k
Citadel Advisors Jun 2025 12k $103k
Royal Bank of Canada Jun 2025 6.2k $53k
Federation des caisses Desjardins du Quebec Jun 2025 5.7k $48k
SBI Securities Jun 2025 5.2k $44k
IFP Advisors Sep 2025 2.3k $21k
Qube Research & Technologies Jun 2025 1.6k $14k
Capital Analysts Jun 2025 1.4k $11k
Edmond De Rothschild Holding Jun 2025 1.3k $11k
Northwestern Mutual Wealth Management Company Jun 2025 550.00 $4.6k
Aptus Capital Advisors Jun 2025 400.00 $3.4k